Denis Katz, MD
Today, advances in molecular biology, biomarker science, neuroimaging, digital phenotyping, and computational analytics are revealing what many investigators have long suspected: conditions such as Alzheimer's disease, Parkinson's disease, major depressive disorder, and neurodegenerative syndromes are not singular diseases but biologically diverse populations grouped under common labels.
Sorry, no members were found.